Pediatric MS patients with a primary progressive-like disease may still have relevant inflammatory activity and may benefit from regular MS treatment

Arlette L Bruijstens, Katelijn M Blok, Joost Smolders, Beatrijs Ha Wokke, Rinze F Neuteboom

Research output: Contribution to journal/periodicalArticleScientificpeer-review

16 Downloads (Pure)
Original languageEnglish
Pages (from-to)1962-1964
JournalMultiple Sclerosis
Publication statusPublished - 2020

Cite this